SAiGENCI recruit recognised with prestigious award
Internationally recognised cancer expert, Professor Brendan Jenkins, has received the International Cytokine and Interferon Society (ICIS) 2023 Distinguished Service Award. He will be presented with the award at the annual ICIS conference in Athens, Greece, in October this year.
[Read more about SAiGENCI recruit recognised with prestigious award]
ENZAMET shows promise as prostate cancer treatment
A new drug combination for men with advanced prostate cancer has shown sustained increase in survival rates.
[Read more about ENZAMET shows promise as prostate cancer treatment]
Top talent to boost cancer research
The search for a tailored treatment for cancerous tumours has been bolstered with the appointment of an internationally recognised expert to the South Australian Immunogenomics Cancer Institute (SAiGENCI).
Placenta research puts spotlight on early weeks of human pregnancy
A University of Adelaide-led research project will deliver important new knowledge in the first weeks of human development to help reduce infertility and pregnancy complications.
[Read more about Placenta research puts spotlight on early weeks of human pregnancy]
Project investigates new approach to combat prostate cancer
A research team led by the University of Adelaide will investigate how prostate cancer cells survive and reappear after drug treatment.
[Read more about Project investigates new approach to combat prostate cancer ]
Leading cancer researcher joins SAiGENCI
Cancer research expert Professor Melissa Davis has been appointed as Program Leader, Cancer Systems Biology at the South Australian immunoGENomics Cancer Institute (SAiGENCI).
Keys to unlocking mysteries of cancer
A crack new team is decoding cancer’s genetic and immunological mysteries right here in South Australia.
Cancer treatment ‘brain-gain’ for South Australia
South Australian patients with cancer will benefit from world-class cancer research and new treatments with the appointment of three globally-lauded scientists to the University of Adelaide’s South Australian immunoGENomics Cancer Institute (SAiGENCI).
[Read more about Cancer treatment ‘brain-gain’ for South Australia]